Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa.
Health economics
South Africa
budgeting
cost data
decision-making
interviews
Journal
Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614
Informations de publication
Date de publication:
11 Nov 2021
11 Nov 2021
Historique:
received:
11
02
2021
revised:
23
05
2021
accepted:
13
06
2021
pubmed:
3
7
2021
medline:
20
11
2021
entrez:
2
7
2021
Statut:
ppublish
Résumé
An increasing focus on the use of the results of cost analyses and other economic evaluations in health programme decision-making by governments, donors and technical support partners working in low- and middle-income countries is accompanied by recognition that this use is impeded by several factors, including the lack of skills, data and coordination between spheres of the government. We describe our experience generating economic evaluation data for human immunodeficiency virus, tuberculosis and sexual/reproductive health programmes in South Africa alongside the results of a series of in-depth interviews (IDIs) among decision-makers within the South African government and implementing organizations (data users) and producers of economic evaluations (data producers). We summarize results across (1) the process of implementing a new intervention; (2) barriers to the use of cost data and suggested solutions and (3) the transferability of experiences to the planned South African implementation of universal health coverage (UHC). Based on our experience and the IDIs, we suggest concrete steps towards the improvement of economic data use in the planning and the establishment of structures mandated under the transition to UHC. Our key recommendations include the following: (1) compile a publicly available and regularly updated in-country cost repository; (2) increase the availability of programmatic outcomes data at the aggregate level; (3) agree upon and implement a set of primary decision criteria for the adoption and funding of interventions; (4) combine the efforts of health economics institutions into a stringent system for health technology assessments and (5) improve the link between national and provincial planning and budgeting.
Identifiants
pubmed: 34212192
pii: 6312946
doi: 10.1093/heapol/czab071
pmc: PMC8597963
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1545-1551Subventions
Organisme : FIC NIH HHS
ID : D43 TW010543
Pays : United States
Organisme : Bill and Melinda Gates Foundation
ID : Improving Data, Systems, and Methods for Estima
Organisme : FIC NIH HHS
ID : D43 TW010543
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
Références
Value Health. 2018 May;21(5):569-572
pubmed: 29753354
Pharmacoeconomics. 2009;27(8):635-43
pubmed: 19712007
Health Policy Plan. 2019 Nov 1;34(9):706-719
pubmed: 31544948
BMC Health Serv Res. 2017 Jan 7;17(1):17
pubmed: 28061899
Health Econ. 2002 Dec;11(8):735-9
pubmed: 12457373
Value Health. 2018 Jul;21(7):759-761
pubmed: 30005746
BMJ. 2013 Mar 25;346:f1049
pubmed: 23529982
Health Econ. 2016 Feb;25 Suppl 1:1-5
pubmed: 26804357
Appl Health Econ Health Policy. 2003;2(3):149-55
pubmed: 14984280
Bull World Health Organ. 2004 Mar;82(3):172-9
pubmed: 15112005